Clinical trial
A Study to Determine if Antibiotics Prevent Infection in the Pancreas of…
NCT00061438 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00061438 |
|---|---|
| Title | A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died |
| Official title | A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pancreatitis, Acute Necrotizing |
| Intervention type | Drug |
| Interventions | meropenem |
| Enrollment | 240 |
| Start date | Feb 1, 2003 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | May 28, 2003 |
| Last update posted | Sep 1, 2017 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: